Botox for Morton's Neuroma

NewsBot · Jun 8, 2013

Members do not see these Ads. Sign Up.
Treatment of Morton Neuroma with Botulinum Toxin A: A Pilot Study.
Climent JM, Mondéjar-Gómez F, Rodríguez-Ruiz C, Díaz-Llopis I, Gómez-Gallego D, Martín-Medina P.
Clin Drug Investig. 2013 Jun 6.

BACKGROUND AND OBJECTIVE:
Morton neuroma is a common cause of metatarsalgia of neuropathic origin. Systematic reviews suggest that insufficient studies have been performed on the efficacy of the different treatments available. OnabotulinumtoxinA has shown a degree of usefulness in other conditions associated with neuropathic pain. The aim of this study was to investigate the therapeutic potential of onabotulinumtoxinA in Morton neuroma.

PATIENTS AND METHODS:
We present an open-label, pilot study with 17 consecutive patients with Morton neuroma and pain of more than 3 months' duration that had not responded to conservative treatment with physical measures or corticosteroid injection. Patients received one onabotulinumtoxinA injection in the area of the neuroma. The main outcome measure was the variation in the pain on walking evaluated using a visual analogue scale (VAS) before treatment and at 1 and 3 months after treatment. The secondary outcome was the change in foot function, which was assessed using the Foot Health Status Questionnaire.

RESULTS:
In the overall group, the mean initial VAS score on walking was 7. This mean score had fallen to 4.8 at 1 month after treatment and to 3.7 at 3 months. Twelve patients (70.6 %) reported an improvement in their pain and five patients (29.4 %) reported no change; exacerbation of the pain did not occur in any patient. Improvements were also observed in two of the dimensions of the Foot Health Status Questionnaire: foot pain, which improved from a mean of 38.88 before treatment to 57 at 3 months, and foot function, which improved from a mean of 42.27 before treatment to 59.9 at 3 months. Clinical variables including age, sex, site and size of the lesion, standing activity, weekly duration of walking, footwear, foot type and footprint had no influence on the outcome. No adverse effects were reported.

CONCLUSIONS:
In this pilot study, injection with onabotulinumtoxinA was shown to be of possible usefulness to relieve the pain and improve function in Morton neuroma. This finding opens the door to further clinical research.
Click to expand...

Admin2 · Jun 8, 2013

Related threads:
Other threads tagged with mortons neuroma
Botox for toe walking
Botulinum toxin and plantar fasciitis
First MPJ disorders treated with Botulinum Toxin
Botox for hyperhidrosis
Botulinum toxin for diabetic neuropathic pain
Botox for diabetic foot ulcers ?

drdebrule · Jun 10, 2013

Yes, but will the insurance companies cover this in the US?

NewsBot The Admin that posts the news.

Admin2 Administrator Staff Member

drdebrule Active Member

Botox for tarsal tunnel syndrome

Botox for compartment syndrome in the leg

Botox use in young adult with 4 x CVA

Botox for toe walking

Botox for the treatment of claw/hammer toes

Podiatrists doing Botox and dermal fillers

New Botox & Fillers course for UK Podiatrists

Share This Page